TUCSON, AZ / ACCESS Newswire / April 29, 2025 / Retatrutide, also known as LY3437943, is an innovative triple receptor agonist targeting glucose-dependent insulinotropic polypeptide (GIP), ...

Objective: To review drug interaction studies of glucagon-like peptide-1 receptor agonists ... target peak concentrations or a rapid onset of action. Studies in patients with type 2 diabetes ...

Drugs that bind to and activate the receptors for the hormones GLP-1 and GIP are effective in the treatment of obesity and ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a group of drugs used to treat type 2 diabetes and sometimes obesity. GLP-1 RAs are very effective at lowering blood sugar levels.

The effects of various agents targeting these gastrointestinal peptide systems ... about the lack of specificity of vildagliptin's action, no notable safety issues emerged in this or other ...

Leveraging AI, researchers have identified a naturally occurring molecule that can suppress appetite and facilitate weight loss in mice and pigs.

Shares of Viking Therapeutics have sold off sharply as the market awaits updates on its drug candidates. The company is ...

Holst and his colleagues received one of the life-science awards this year "for the discovery and characterization of glucagon-like peptide 1 and ... that just mimics the action of GLP-1, Holst ...